美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

The Nightview Fund

35.58

-0.0809-0.23%

盤後：35.33-0.2450-0.69%16:10 EST

成交量：1,346.00

成交額：4.78萬

市值：2,859.40萬

市盈率：- -

高：35.58

開：35.55

低：35.33

收：35.66

52周最高：38.42

52周最低：22.38

股本：80.38萬

流通股本：80.38萬

量比：1.47

換手率：0.17%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

The Nightview Fund

交易所：

ARCA

成立時間：

2018

員工人數：

- -

公司地址：

10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States

官網：

http://www.nightstartx.com

郵編：

73120

電話：

傳真：

405-896-5825

簡介：

Nightstar Therapeutics Plc最初於2013年5月根據英格蘭和威爾士的法律成立，隨後於2014年1月更名為NightstaRx Limited。該公司是一家領先的臨床階段基因治療公司，專註於開發和治療藥物患有罕見的遺傳性視網膜疾病，否則會進入失明。利用他們在眼科，基因治療和藥物開發方面的專業知識，他們正在開發一系列專有產品候選人，旨在大幅度修改或停止目前尚未批準的治療的遺傳性視網膜疾病的進展。他們的任務是維護和通過構建領先的垂直整合視網膜基因治療公司，恢復患者的視力。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NITE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"NITE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NITE\",,,,,undefined,":{"symbol":"NITE","market":"US","secType":"STK","nameCN":"The Nightview Fund","latestPrice":35.575,"timestamp":1771621200000,"preClose":35.6559,"halted":0,"volume":1346,"hourTrading":{"tag":"盘后","latestPrice":35.33,"preClose":35.575,"latestTime":"16:10 EST","volume":2,"amount":71.15,"timestamp":1771621804570,"change":-0.245,"changeRate":-0.006887,"amplitude":0},"delay":0,"changeRate":-0.0022689092127810475,"floatShares":803768,"shares":803768,"eps":0,"marketStatus":"休市中","change":-0.0809,"latestTime":"02-20 16:00:00 EST","open":35.55,"high":35.575,"low":35.33,"amount":47801.9075,"amplitude":0.006871,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1506571200000,"exchange":"ARCA","adjPreClose":35.6559,"sharesOutstanding":803768,"nav":35.58,"aum":28599729.98,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.33,"preClose":35.575,"latestTime":"16:10 EST","volume":2,"amount":71.15,"timestamp":1771621804570,"change":-0.245,"changeRate":-0.006887,"amplitude":0},"volumeRatio":1.4681502313847303},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NITE\",,,,,undefined,":{"symbol":"NITE","floatShares":803768,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.4681502313847303,"shares":803768,"dividePrice":0,"high":35.575,"amplitude":0.006871,"preClose":35.6559,"low":35.33,"week52Low":22.38,"pbRate":"--","week52High":38.42,"institutionHeld":0,"latestPrice":35.575,"eps":0,"divideRate":0,"volume":1346,"delay":0,"ttmEps":0,"open":35.55,"prevYearClose":36.612,"prevWeekClose":35.2201,"prevMonthClose":36.9198,"prevQuarterClose":36.612,"fiveDayClose":35.13,"twentyDayClose":38.3352,"sixtyDayClose":33.9485},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NITE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NITE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NITE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1858671235,"yearFounded":2018,"address":"10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States","zipCode":"73120","officePhone":"405-778-8377","officeFax":"405-896-5825"},"stockCompanyDetail":{"websiteUrl":"http://www.nightstartx.com","stockEarnings":[{"period":"1week","weight":0.0101},{"period":"1month","weight":-0.0547},{"period":"3month","weight":0.0479},{"period":"6month","weight":0.0765},{"period":"1year","weight":0.1437},{"period":"ytd","weight":-0.0283}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Nightstar Therapeutics Plc最初於2013年5月根據英格蘭和威爾士的法律成立，隨後於2014年1月更名為NightstaRx Limited。該公司是一家領先的臨床階段基因治療公司，專註於開發和治療藥物患有罕見的遺傳性視網膜疾病，否則會進入失明。利用他們在眼科，基因治療和藥物開發方面的專業知識，他們正在開發一系列專有產品候選人，旨在大幅度修改或停止目前尚未批準的治療的遺傳性視網膜疾病的進展。他們的任務是維護和通過構建領先的垂直整合視網膜基因治療公司，恢復患者的視力。","exchange":"ARCA","name":"The Nightview Fund","nameEN":"The Nightview Fund"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NITE\",market:\"US\",,,undefined,":null}}